VERTEX PHARMACEUTICALS (BELGIUM)

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Alexander MANGANIELLO",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": "2025-11-21",
      "evidence_quote": "De algemene vergadering neemt kennis van het ontslag van Alexander MANGANIELLO als bestuurder van de Vennootschap met ingang van 21 november 2025.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Omar WHITE",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": "2025-11-21",
      "evidence_quote": "De algemene vergadering beslist om Omar WHITE, te dien einde woonstkeuze doende op de zetel van de Vennootschap, te benoemen als bestuurder van de Vennootschap met ingang van 21 november 2025.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": null,
      "person": {
        "rrn": null,
        "name": "LE HUR-GURUNLIAN Maryse",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-11-21",
      "evidence_quote": "De raad van bestuur van de Vennootschap is derhalve als volgt samengesteld met ingang vanaf 21 november 2025: \u2022 LE HUR-GURUNLIAN Maryse, bestuurder",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": null,
      "person": {
        "rrn": null,
        "name": "THOMBRE Prasanna",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-11-21",
      "evidence_quote": "De raad van bestuur van de Vennootschap is derhalve als volgt samengesteld met ingang vanaf 21 november 2025: \u2022 THOMBRE Prasanna. bestuurder",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": null,
      "person": {
        "rrn": null,
        "name": "WHITE Omar",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2025-11-21",
      "evidence_quote": "De raad van bestuur van de Vennootschap is derhalve als volgt samengesteld met ingang vanaf 21 november 2025: \u2022 WHITE Omar. bestuurder",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "gevolmachtigde",
      "person": {
        "rrn": null,
        "name": "Filip Van Acoleyen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Deloitte Legal - Lawyers",
        "address": "Gateway building, 1930 Zaventem, Luchthaven Brussel Nationaal 1 J",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering beslist om een bijzondere volmacht toe te kennen aan Filip Van Acoleyen, Nicolas Bosschaerts, Anthea Debou, Brent Mastin en Simon Meyskens, medewerkers van het advocatenbureau Deloitte Legal - Lawyers, te dien einde woonstkeuze doende te Gateway building, 1930 Zaventem, Lucht",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Brussel",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2026-02-24",
    "filing_date": "2026-02-17",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2026-01-22",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0781.749.031",
    "name_full": "Vertex Pharmaceuticals (Belgium)",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Deloitte Legal - Lawyers",
    "person_name": null,
    "org_rep_person_name": "Anthea Debou",
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Prasanna THOMBRE",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-07-01",
      "evidence_quote": "De algemene vergadering beslist om volgende personen te benoemen als bestuurders: Prasanna THOMBRE, te dien einde woonstkeuze doende op de zetel van de Vennootschap, met ingang van 1 juli 2025."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Alexander MANGANIELLO",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-07-01",
      "evidence_quote": "De algemene vergadering beslist om volgende personen te benoemen als bestuurders: Alexander MANGANIELLO, te dien einde woonstkeuze doende op de zetel van de Vennootschap, met ingang van 1 juli 2025."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0781.749.031",
    "name_full": "VERTEX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Filip SIMPELAERE",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0446334711",
        "name": "Ernst en Young Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering beslist om het mandaat van de commissaris, Ernst en Young Bedrijfsrevisoren (ondernemingsnummer: 0446.334.711), met zetel te Kouterveldstraat 7B bus 1, 1831 Machelen, te hernieuwen voor een termijn van drie boekjaren, waarvan het eerste eindigt op 31 december 2025. Deze venno"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0781.749.031",
    "name_full": "VERTEX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Brussel",
        "region": "Brussels Gewest",
        "street": "Montoyerstraat",
        "country": "BE",
        "postcode": "1000",
        "box_number": null,
        "street_number": "47"
      },
      "old_address": {
        "city": "Brussel",
        "region": "Brussels Gewest",
        "street": "Robert Schumanplein",
        "country": "BE",
        "postcode": "1040",
        "box_number": null,
        "street_number": "11"
      },
      "effective_date": "2024-05-14",
      "evidence_quote": "De zetel van de Vennootschap, alsook de vestigingseenheid van de Vennootschap, te verplaatsen van Robert Schumanplein 11, 1040 Brussel naar Montoyerstraat 47, 3rde verdieping, 1000 Brussel met ingang van 14 mei 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0781.749.031",
    "name_full": "VERTEX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Filip Simpelaere",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Ernst en Young Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering benoemt Ernst en Young Bedrijfsrevisoren, met zetel te De Kleetlaan 2, 1831 Machelen, als commissaris van de Vennootschap voor een termijn van drie boekjaren, waarvan het eerste boekjaar eindigt op 31 december 2022. Deze vennootschap heeft Filip Simpelaere, bedrijfsrevisor, a"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0781.749.031",
    "name_full": "VERTEX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "BV"
  }
}

{
  "kind": "oprichting",
  "seat": "1040 Brussel, Robert Schumanplein 11",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": "0771.668.751",
        "name": "VERTEX PHARMACEUTICALS (EUROPE) Ltd"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "naam",
      "partner_role": null,
      "holder_org_kbo": "0771.668.751",
      "holder_org_name": "VERTEX PHARMACEUTICALS (EUROPE) Ltd",
      "contribution_type": "cash",
      "amount_paid_in_eur": 20000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 1000,
      "amount_subscribed_eur": 20000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 20000,
  "subject_company": {
    "kbo": "0781.749.031",
    "name_full": "VERTEX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "BV"
  },
  "initial_directors": [],
  "incorporation_date": "2022-02-07",
  "post_incorporation_mandates": []
}